Product Distribution

September 5, 2024

Are The Newest Weight Loss Drugs Also Good To Be Real? Uc San Francisco

What Doctors Desire Individuals Learnt About Anti-obesity Medicine American Medical Association Phentermine-topiramate is not recommended for people with significant heart background such as coronary illness and unchecked hypertension (64 ). However, in people without coronary condition and with...

Read more →
September 5, 2024

Anti-obesity Drug Exploration: Breakthroughs And Obstacles Nature Assesses Medication Discovery

Tesofensine Wikipedia In recap, long-acting GIPR agonists have actually been revealed to lower body weight and to boost sugar handling in a series of preclinical studies184,185 and a long-acting GIPR agonist is in stage I clinical trials for the therapy of T2D (Table 2) (see Associated web...

Read more →
September 5, 2024

Randomized Controlled Test Of Tesomet For Weight-loss In Hypothalamic Obesity European Journal Of Endocrinology

Randomized Regulated Trial Of Tesomet For Weight Loss In Hypothalamic Obesity European Journal Of Endocrinology Unfortunately, this research was stopped by the NIH IRB as a result of factors unrelated to damaging medicine effects or efficacy (reinterpretation of the Typical Policy for human subject...

Read more →
September 5, 2024

Anti-obesity Medication Discovery: Advancements And Obstacles Nature Assesses Medicine Exploration

Anti-obesity Medication Discovery: Advances And Challenges Nature Reviews Drug Discovery Very just recently, it was shown that CNS loss of GIPR makes mice immune to GIP-induced body weight management, suggesting that GIP manages basal metabolism using CNS GIPR signalling185. Confirming the...

Read more →
September 5, 2024

Having A Hard Time To Accomplish Fat Burning Goals? Uncover The Power Of Tesofensine And Glp-1 Agonists!

Pharmaceuticals Free Full-text Pharmacological Treatments And Natural Biocompounds In Weight Administration Excessive weight wasnot recognized as a chronic condition up until 1985 by the scientific neighborhood and2013 by the medical community. Pharmacotherapy for obesity has advancedremarkably...

Read more →
Welcome to MediQuest Pharmaceuticals, where innovation meets excellence in the pharmaceutical industry. I am Michael Johnson, the founder and driving force behind MediQuest Pharmaceuticals. With over two decades of experience in drug development and pharmaceutical regulations, I have dedicated my career to advancing healthcare through innovative pharmaceutical solutions. Born and raised in the bustling city of Boston, my fascination with science began at a young age, nurtured by countless hours spent in the local library reading about chemistry and biology. This passion led me to pursue a degree in Medicinal Chemistry at the University of Massachusetts, followed by a Ph.D. in Pharmaceutical Sciences. After completing my education, I ventured into the pharmaceutical industry, where I gained extensive experience in various facets of drug development and manufacturing.